FRASCA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 2.550
EU - Europa 1.834
AS - Asia 467
AF - Africa 216
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
SA - Sud America 2
Totale 5.078
Nazione #
US - Stati Uniti d'America 2.409
IT - Italia 618
IE - Irlanda 451
CN - Cina 375
UA - Ucraina 364
CI - Costa d'Avorio 164
DE - Germania 141
CA - Canada 140
RU - Federazione Russa 103
SN - Senegal 48
SE - Svezia 39
GB - Regno Unito 30
FR - Francia 26
VN - Vietnam 23
IN - India 21
IR - Iran 19
CH - Svizzera 18
UZ - Uzbekistan 11
BE - Belgio 9
PL - Polonia 8
GR - Grecia 7
NL - Olanda 7
EU - Europa 5
AU - Australia 4
BG - Bulgaria 4
NG - Nigeria 4
TR - Turchia 4
LB - Libano 3
SG - Singapore 3
FI - Finlandia 2
KZ - Kazakistan 2
AT - Austria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HK - Hong Kong 1
HR - Croazia 1
KH - Cambogia 1
KR - Corea 1
MK - Macedonia 1
MX - Messico 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 5.078
Città #
Chandler 499
Dublin 450
Jacksonville 392
Houston 238
Abidjan 164
Catania 145
Quintano 131
Ashburn 128
Nanjing 127
Cambridge 123
Lawrence 122
Andover 120
Toronto 111
Grafing 79
Wilmington 71
Boardman 63
San Mateo 62
Des Moines 59
Dakar 48
Nanchang 44
Bremen 40
Hebei 34
Jiaxing 31
Saint Petersburg 29
Shenyang 29
Ottawa 28
Changsha 23
Tianjin 22
Bari 20
Ardabil 16
Aci Catena 14
Dong Ket 13
Rome 13
Augusta 11
Beijing 11
Palermo 11
Pune 11
Washington 10
Brussels 9
Leawood 9
Moscow 9
Paternò 9
Hanoi 8
Jinan 8
Misterbianco 8
Redwood City 8
Falls Church 7
Norwalk 6
Pozzo Di Gotto 6
Seattle 6
Ann Arbor 5
Edinburgh 5
Guangzhou 5
L'hay-les-roses 5
Manchester 5
Milan 5
San Francisco 5
Abuja 4
Assago 4
Cisano Bergamasco 4
Hangzhou 4
Kunming 4
London 4
Santa Venerina 4
Amsterdam 3
Den Haag 3
Frankfurt Am Main 3
Liberty Lake 3
Messina 3
Ningbo 3
Philadelphia 3
Portland 3
Siracusa 3
Trivandrum 3
Acireale 2
Adrano 2
Agrigento 2
Aidone 2
Brindisi 2
Cho Ha 2
Crema 2
Fairfield 2
Fiumefreddo Di Sicilia 2
Foggia 2
Frankfurt am Main 2
Fremont 2
Gela 2
Helsinki 2
Kiev 2
Lago 2
Lanzhou 2
Leinfelden-echterdingen 2
Ludwigshafen 2
Melilli 2
Mersin 2
Monmouth Junction 2
Munich 2
Napoli 2
New Delhi 2
Padova 2
Totale 3.780
Nome #
Peroxisomal proliferator-activated receptor-γ agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells 284
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes 238
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 61
Different Effects of the Insulin Receptor Isoforms on 32D Cell Growth and Differentiation 58
17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells 58
Insulin receptor isoforms in physiology and disease: An updated view 58
Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway 57
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels 57
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 55
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells 54
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes 54
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism 54
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 53
Curcumin, hormesis and the nervous system 53
c-Abl and insulin receptor signalling 53
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 52
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 52
BRAF(V600E) mutation and the biology of papillary thyroid cancer 51
p53 family proteins in thyroid cancer 50
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 50
Challenges in the treatment of parathyroid carcinoma: a case report 50
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 49
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 49
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 48
Papillary thyroid cancer incidence in the volcanic area of Sicily 48
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 48
Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience 48
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved 47
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 47
Cytological diagnosis difficulties in hyalinizing trabecular adenoma of the thyroid 46
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 46
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 46
The isoform A of the insulin receptor as a regulator of the IGF system 45
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 45
p73 tumor-suppressor activity is impaired in human thyroid cancer 44
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 44
Le cellule staminali tiroidee, isolate da gozzi di soggetti adulti, crescono in aggregati sferici in risposta a stimolazione con fattori di crescita e necessitano del TSH per differenziare in Tireociti maturi 44
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 44
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 43
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 43
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 43
The p53-homologue p63 may promote thyroid cancer progression 42
Thyrospheres an in vitro model for human thyroid carcinogenesis 42
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 42
HMGA1 inhibits the function of p53 family members in thyroid cancer cells 42
Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells 41
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 41
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 41
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 40
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription 39
Isolation and characteriziation of cancer thyrospheres 39
Different FT3/TSH correlation in acquired and congenital hypothyroid patients reveals a different hypothalamic set-point 38
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 38
Obesity, insulin-resistance and cancer 38
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism 38
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells 38
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 38
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 38
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 37
IGF and insulin receptor signaling in breast cancer 37
Seasonal Variations in TSH Serum Levels in Athyreotic Patients under L-Thyroxine Replacement Monotherapy. 37
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease 37
Surveillance of patients with differentiated thyroid cancer and indeterminate response: a longitudinal study on basal thyroglobulin trend 37
The role of insulin receptor isoform a (IR-A) in cancer 37
The role of insulin receptors and IGF-I receptors in cancer and other diseases 36
Diabetes and cancer 36
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling 36
Updates on the management of advanced, metastatic, and radioiodine refractory differentiated thyroid cancer 36
Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway 36
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 36
Thyroid Cancer and Circadian Clock Disruption 36
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years 35
Early detection of suspicious lymph nodes in differentiated thyroid cancer 34
Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity 34
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. 34
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients 34
Registro tumori tiroidei di Sicilia: studi di epidemiologia molecolare 34
Sintesi del mechano growth factor (MGF) umano ricombinante nell’Escherichia coli 34
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity 34
Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves' Ophthalmopathy to Parenteral Corticosteroids 34
Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression 34
GENOME WIDE ANALYSIS IN PAPILLARY THYROID CARCINOMA 33
Insulin-like growth factor II stimulates cell growth through the insulin receptor in brest cancer: a newly identified autocrine/paracrine loop 33
Expression of neurotrophins, GDNF and their receptors in rat thyroid tissue 33
Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement 33
Re:Insulin, Insulin-like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women 33
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 33
Insulin receptors in breast cancer 33
Early Massive Fibrosis of a Single Extraocular Muscle Causing Severe Unilateral Euthyroid Graves' Ophthalmopathy in a Patient with Hypercholesterolemia Who Smokes 32
Insulin/IGF-I hybrid receptors are highly expressed in human breast cancer and are activated by IGF-I 32
The Insulin Receptor in Breast Cancer 32
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 32
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 32
The expression of PTEN tumor suppressor is down regulated by the dominant negative p73 isoform ΔNp73 in thyroid cancer cells 30
Role of c-Abl tyrosine Kinase in Insulin and IGF-I signaling 30
Obesity and cancer 30
Thyroid Tumor Registry of Sicily: Molecular Epidemiology 29
Genetica dei Tumori Tiroidei 29
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes. 29
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 29
Totale 4.556
Categoria #
all - tutte 16.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201953 0 0 0 0 0 0 0 0 0 5 10 38
2019/2020832 263 88 103 54 74 4 64 3 59 15 74 31
2020/2021828 10 59 82 2 186 22 87 14 160 24 150 32
2021/2022979 116 135 29 21 133 13 161 37 84 6 28 216
2022/20231.732 133 48 34 321 152 283 4 266 391 21 48 31
2023/2024598 43 133 37 58 44 161 43 65 7 7 0 0
Totale 5.304